 | • レポートコード：GIR-23F3872 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Non-prescription Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の一般用医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 一般用医薬品市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・先発医薬品、ジェネリック医薬品 アプリケーション別セグメントは次のように区分されます。 ・病院、診療所、その他 世界の一般用医薬品市場の主要なマーケットプレーヤーは以下のとおりです。 ・Pfizer、Roche、Sanofi、Johnson & Johnson、Merck & Co. (MSD)、Novartis、AbbVie、Gilead Sciences、GlaxoSmithKline (GSK)、Amgen、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Teva、Bayer、Novo Nordisk、Allergan、Takeda、Boehringer Ingelheim、Takeda 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 一般用医薬品の概要 - タイプ別分析（2017年vs2021年vs2028年）：先発医薬品、ジェネリック医薬品 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、診療所、その他 - 世界の一般用医薬品市場規模・予測 - 世界の一般用医薬品生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pfizer、Roche、Sanofi、Johnson & Johnson、Merck & Co. (MSD)、Novartis、AbbVie、Gilead Sciences、GlaxoSmithKline (GSK)、Amgen、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Teva、Bayer、Novo Nordisk、Allergan、Takeda、Boehringer Ingelheim、Takeda ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：先発医薬品、ジェネリック医薬品 ・アプリケーション別分析2017年-2028年：病院、診療所、その他 ・一般用医薬品の北米市場分析 - 一般用医薬品の北米市場：タイプ別市場規模2017年-2028年 - 一般用医薬品の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・一般用医薬品のヨーロッパ市場分析 - ：一般用医薬品のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：一般用医薬品のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・一般用医薬品のアジア太平洋市場分析 - 一般用医薬品のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 一般用医薬品のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・一般用医薬品の南米市場分析 - 一般用医薬品の南米市場：タイプ別市場規模2017年-2028年 - 一般用医薬品の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・一般用医薬品の中東・アフリカ市場分析 - 一般用医薬品の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 一般用医薬品の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Non-prescription Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Non-prescription Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Non-prescription Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Brand Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Non-prescription Drugs include Pfizer, Roche, Sanofi, Johnson & Johnson, and Merck & Co. (MSD), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-prescription Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Brand Drugs
Generic Drug
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Non-prescription Drugs market are listed below:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Takeda
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-prescription Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-prescription Drugs, with price, sales, revenue and global market share of Non-prescription Drugs from 2019 to 2022.
Chapter 3, the Non-prescription Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-prescription Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Non-prescription Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-prescription Drugs.
Chapter 13, 14, and 15, to describe Non-prescription Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Non-prescription Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-prescription Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-prescription Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Non-prescription Drugs Market Size & Forecast
1.4.1 Global Non-prescription Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Non-prescription Drugs Sales in Volume (2017-2028)
1.4.3 Global Non-prescription Drugs Price (2017-2028)
1.5 Global Non-prescription Drugs Production Capacity Analysis
1.5.1 Global Non-prescription Drugs Total Production Capacity (2017-2028)
1.5.2 Global Non-prescription Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-prescription Drugs Market Drivers
1.6.2 Non-prescription Drugs Market Restraints
1.6.3 Non-prescription Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Non-prescription Drugs Product and Services
2.1.4 Pfizer Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Non-prescription Drugs Product and Services
2.2.4 Roche Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Non-prescription Drugs Product and Services
2.3.4 Sanofi Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Non-prescription Drugs Product and Services
2.4.4 Johnson & Johnson Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck & Co. (MSD)
2.5.1 Merck & Co. (MSD) Details
2.5.2 Merck & Co. (MSD) Major Business
2.5.3 Merck & Co. (MSD) Non-prescription Drugs Product and Services
2.5.4 Merck & Co. (MSD) Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Non-prescription Drugs Product and Services
2.6.4 Novartis Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business
2.7.3 AbbVie Non-prescription Drugs Product and Services
2.7.4 AbbVie Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Gilead Sciences
2.8.1 Gilead Sciences Details
2.8.2 Gilead Sciences Major Business
2.8.3 Gilead Sciences Non-prescription Drugs Product and Services
2.8.4 Gilead Sciences Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 GlaxoSmithKline (GSK)
2.9.1 GlaxoSmithKline (GSK) Details
2.9.2 GlaxoSmithKline (GSK) Major Business
2.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Product and Services
2.9.4 GlaxoSmithKline (GSK) Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Non-prescription Drugs Product and Services
2.10.4 Amgen Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Non-prescription Drugs Product and Services
2.11.4 AstraZeneca Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Bristol-Myers Squibb
2.12.1 Bristol-Myers Squibb Details
2.12.2 Bristol-Myers Squibb Major Business
2.12.3 Bristol-Myers Squibb Non-prescription Drugs Product and Services
2.12.4 Bristol-Myers Squibb Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Non-prescription Drugs Product and Services
2.13.4 Eli Lilly Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Teva
2.14.1 Teva Details
2.14.2 Teva Major Business
2.14.3 Teva Non-prescription Drugs Product and Services
2.14.4 Teva Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Non-prescription Drugs Product and Services
2.15.4 Bayer Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Novo Nordisk
2.16.1 Novo Nordisk Details
2.16.2 Novo Nordisk Major Business
2.16.3 Novo Nordisk Non-prescription Drugs Product and Services
2.16.4 Novo Nordisk Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Allergan
2.17.1 Allergan Details
2.17.2 Allergan Major Business
2.17.3 Allergan Non-prescription Drugs Product and Services
2.17.4 Allergan Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Takeda
2.18.1 Takeda Details
2.18.2 Takeda Major Business
2.18.3 Takeda Non-prescription Drugs Product and Services
2.18.4 Takeda Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Boehringer Ingelheim
2.19.1 Boehringer Ingelheim Details
2.19.2 Boehringer Ingelheim Major Business
2.19.3 Boehringer Ingelheim Non-prescription Drugs Product and Services
2.19.4 Boehringer Ingelheim Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Takeda
2.20.1 Takeda Details
2.20.2 Takeda Major Business
2.20.3 Takeda Non-prescription Drugs Product and Services
2.20.4 Takeda Non-prescription Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Non-prescription Drugs Breakdown Data by Manufacturer
3.1 Global Non-prescription Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Non-prescription Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Non-prescription Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Non-prescription Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Non-prescription Drugs Manufacturer Market Share in 2021
3.5 Global Non-prescription Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Non-prescription Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Non-prescription Drugs Market Size by Region
4.1.1 Global Non-prescription Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Non-prescription Drugs Revenue by Region (2017-2028)
4.2 North America Non-prescription Drugs Revenue (2017-2028)
4.3 Europe Non-prescription Drugs Revenue (2017-2028)
4.4 Asia-Pacific Non-prescription Drugs Revenue (2017-2028)
4.5 South America Non-prescription Drugs Revenue (2017-2028)
4.6 Middle East and Africa Non-prescription Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Non-prescription Drugs Sales in Volume by Type (2017-2028)
5.2 Global Non-prescription Drugs Revenue by Type (2017-2028)
5.3 Global Non-prescription Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Non-prescription Drugs Sales in Volume by Application (2017-2028)
6.2 Global Non-prescription Drugs Revenue by Application (2017-2028)
6.3 Global Non-prescription Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Non-prescription Drugs Sales by Type (2017-2028)
7.2 North America Non-prescription Drugs Sales by Application (2017-2028)
7.3 North America Non-prescription Drugs Market Size by Country
7.3.1 North America Non-prescription Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Non-prescription Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Non-prescription Drugs Sales by Type (2017-2028)
8.2 Europe Non-prescription Drugs Sales by Application (2017-2028)
8.3 Europe Non-prescription Drugs Market Size by Country
8.3.1 Europe Non-prescription Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Non-prescription Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Non-prescription Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Non-prescription Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Non-prescription Drugs Market Size by Region
9.3.1 Asia-Pacific Non-prescription Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Non-prescription Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Non-prescription Drugs Sales by Type (2017-2028)
10.2 South America Non-prescription Drugs Sales by Application (2017-2028)
10.3 South America Non-prescription Drugs Market Size by Country
10.3.1 South America Non-prescription Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Non-prescription Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Non-prescription Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Non-prescription Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Non-prescription Drugs Market Size by Country
11.3.1 Middle East & Africa Non-prescription Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Non-prescription Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Non-prescription Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Non-prescription Drugs
12.3 Non-prescription Drugs Production Process
12.4 Non-prescription Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-prescription Drugs Typical Distributors
13.3 Non-prescription Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Non-prescription Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Non-prescription Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Non-prescription Drugs Product and Services
Table 6. Pfizer Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Major Business
Table 9. Roche Non-prescription Drugs Product and Services
Table 10. Roche Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Non-prescription Drugs Product and Services
Table 14. Sanofi Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Non-prescription Drugs Product and Services
Table 18. Johnson & Johnson Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck & Co. (MSD) Basic Information, Manufacturing Base and Competitors
Table 20. Merck & Co. (MSD) Major Business
Table 21. Merck & Co. (MSD) Non-prescription Drugs Product and Services
Table 22. Merck & Co. (MSD) Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Non-prescription Drugs Product and Services
Table 26. Novartis Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. AbbVie Basic Information, Manufacturing Base and Competitors
Table 28. AbbVie Major Business
Table 29. AbbVie Non-prescription Drugs Product and Services
Table 30. AbbVie Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 32. Gilead Sciences Major Business
Table 33. Gilead Sciences Non-prescription Drugs Product and Services
Table 34. Gilead Sciences Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. GlaxoSmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table 36. GlaxoSmithKline (GSK) Major Business
Table 37. GlaxoSmithKline (GSK) Non-prescription Drugs Product and Services
Table 38. GlaxoSmithKline (GSK) Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Amgen Basic Information, Manufacturing Base and Competitors
Table 40. Amgen Major Business
Table 41. Amgen Non-prescription Drugs Product and Services
Table 42. Amgen Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Non-prescription Drugs Product and Services
Table 46. AstraZeneca Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 48. Bristol-Myers Squibb Major Business
Table 49. Bristol-Myers Squibb Non-prescription Drugs Product and Services
Table 50. Bristol-Myers Squibb Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 52. Eli Lilly Major Business
Table 53. Eli Lilly Non-prescription Drugs Product and Services
Table 54. Eli Lilly Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Teva Basic Information, Manufacturing Base and Competitors
Table 56. Teva Major Business
Table 57. Teva Non-prescription Drugs Product and Services
Table 58. Teva Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Bayer Basic Information, Manufacturing Base and Competitors
Table 60. Bayer Major Business
Table 61. Bayer Non-prescription Drugs Product and Services
Table 62. Bayer Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 64. Novo Nordisk Major Business
Table 65. Novo Nordisk Non-prescription Drugs Product and Services
Table 66. Novo Nordisk Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Allergan Basic Information, Manufacturing Base and Competitors
Table 68. Allergan Major Business
Table 69. Allergan Non-prescription Drugs Product and Services
Table 70. Allergan Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Takeda Basic Information, Manufacturing Base and Competitors
Table 72. Takeda Major Business
Table 73. Takeda Non-prescription Drugs Product and Services
Table 74. Takeda Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 76. Boehringer Ingelheim Major Business
Table 77. Boehringer Ingelheim Non-prescription Drugs Product and Services
Table 78. Boehringer Ingelheim Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Takeda Basic Information, Manufacturing Base and Competitors
Table 80. Takeda Major Business
Table 81. Takeda Non-prescription Drugs Product and Services
Table 82. Takeda Non-prescription Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Global Non-prescription Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 84. Global Non-prescription Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 85. Market Position of Manufacturers in Non-prescription Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 86. Global Non-prescription Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and Non-prescription Drugs Production Site of Key Manufacturer
Table 88. Non-prescription Drugs New Entrant and Capacity Expansion Plans
Table 89. Non-prescription Drugs Mergers & Acquisitions in the Past Five Years
Table 90. Global Non-prescription Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Global Non-prescription Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Global Non-prescription Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Global Non-prescription Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Global Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Global Non-prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Global Non-prescription Drugs Revenue by Type (2017-2022) & (USD Million)
Table 97. Global Non-prescription Drugs Revenue by Type (2023-2028) & (USD Million)
Table 98. Global Non-prescription Drugs Price by Type (2017-2022) & (USD/Unit)
Table 99. Global Non-prescription Drugs Price by Type (2023-2028) & (USD/Unit)
Table 100. Global Non-prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 101. Global Non-prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 102. Global Non-prescription Drugs Revenue by Application (2017-2022) & (USD Million)
Table 103. Global Non-prescription Drugs Revenue by Application (2023-2028) & (USD Million)
Table 104. Global Non-prescription Drugs Price by Application (2017-2022) & (USD/Unit)
Table 105. Global Non-prescription Drugs Price by Application (2023-2028) & (USD/Unit)
Table 106. North America Non-prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 107. North America Non-prescription Drugs Sales by Country (2023-2028) & (K Units)
Table 108. North America Non-prescription Drugs Revenue by Country (2017-2022) & (USD Million)
Table 109. North America Non-prescription Drugs Revenue by Country (2023-2028) & (USD Million)
Table 110. North America Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 111. North America Non-prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 112. North America Non-prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 113. North America Non-prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Europe Non-prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 115. Europe Non-prescription Drugs Sales by Country (2023-2028) & (K Units)
Table 116. Europe Non-prescription Drugs Revenue by Country (2017-2022) & (USD Million)
Table 117. Europe Non-prescription Drugs Revenue by Country (2023-2028) & (USD Million)
Table 118. Europe Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 119. Europe Non-prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 120. Europe Non-prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 121. Europe Non-prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 122. Asia-Pacific Non-prescription Drugs Sales by Region (2017-2022) & (K Units)
Table 123. Asia-Pacific Non-prescription Drugs Sales by Region (2023-2028) & (K Units)
Table 124. Asia-Pacific Non-prescription Drugs Revenue by Region (2017-2022) & (USD Million)
Table 125. Asia-Pacific Non-prescription Drugs Revenue by Region (2023-2028) & (USD Million)
Table 126. Asia-Pacific Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 127. Asia-Pacific Non-prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 128. Asia-Pacific Non-prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 129. Asia-Pacific Non-prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 130. South America Non-prescription Drugs Sales by Country (2017-2022) & (K Units)
Table 131. South America Non-prescription Drugs Sales by Country (2023-2028) & (K Units)
Table 132. South America Non-prescription Drugs Revenue by Country (2017-2022) & (USD Million)
Table 133. South America Non-prescription Drugs Revenue by Country (2023-2028) & (USD Million)
Table 134. South America Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 135. South America Non-prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 136. South America Non-prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 137. South America Non-prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 138. Middle East & Africa Non-prescription Drugs Sales by Region (2017-2022) & (K Units)
Table 139. Middle East & Africa Non-prescription Drugs Sales by Region (2023-2028) & (K Units)
Table 140. Middle East & Africa Non-prescription Drugs Revenue by Region (2017-2022) & (USD Million)
Table 141. Middle East & Africa Non-prescription Drugs Revenue by Region (2023-2028) & (USD Million)
Table 142. Middle East & Africa Non-prescription Drugs Sales by Type (2017-2022) & (K Units)
Table 143. Middle East & Africa Non-prescription Drugs Sales by Type (2023-2028) & (K Units)
Table 144. Middle East & Africa Non-prescription Drugs Sales by Application (2017-2022) & (K Units)
Table 145. Middle East & Africa Non-prescription Drugs Sales by Application (2023-2028) & (K Units)
Table 146. Non-prescription Drugs Raw Material
Table 147. Key Manufacturers of Non-prescription Drugs Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Non-prescription Drugs Typical Distributors
Table 151. Non-prescription Drugs Typical Customers
List of Figures
Figure 1. Non-prescription Drugs Picture
Figure 2. Global Non-prescription Drugs Revenue Market Share by Type in 2021
Figure 3. Brand Drugs
Figure 4. Generic Drug
Figure 5. Global Non-prescription Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Non-prescription Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Non-prescription Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Non-prescription Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Non-prescription Drugs Price (2017-2028) & (USD/Unit)
Figure 13. Global Non-prescription Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Non-prescription Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Non-prescription Drugs Market Drivers
Figure 16. Non-prescription Drugs Market Restraints
Figure 17. Non-prescription Drugs Market Trends
Figure 18. Global Non-prescription Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Non-prescription Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Non-prescription Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Non-prescription Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Non-prescription Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Non-prescription Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Non-prescription Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Non-prescription Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Non-prescription Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Non-prescription Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Non-prescription Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Non-prescription Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Non-prescription Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Non-prescription Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Non-prescription Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Non-prescription Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Non-prescription Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Non-prescription Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Non-prescription Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Non-prescription Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Non-prescription Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Non-prescription Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Non-prescription Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Non-prescription Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Non-prescription Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Non-prescription Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Non-prescription Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Non-prescription Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Non-prescription Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Non-prescription Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Non-prescription Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Non-prescription Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Non-prescription Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Non-prescription Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Non-prescription Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Non-prescription Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Non-prescription Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Non-prescription Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Non-prescription Drugs in 2021
Figure 77. Manufacturing Process Analysis of Non-prescription Drugs
Figure 78. Non-prescription Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
| 【一般用医薬品について】 一般用医薬品、または非処方薬は、医師の処方なしに購入できる医薬品のことを指します。これらの薬は、軽度の疾患や症状の予防や治療に使用されることが一般的です。一般用医薬品は、広く市販されており、多くの国では薬局やコンビニエンスストアなどで簡単に手に入れることができます。ここでは一般用医薬品の概念について定義、特徴、種類、用途、関連技術などについて詳しく説明します。 まず一般用医薬品の定義ですが、処方箋が必要ない医薬品であるため、患者が自己判断で使用することが前提となっています。このため、一般用医薬品は比較的安全性が高く、副作用や相互作用が少ないものが求められます。製薬会社は、一般用医薬品を市場に出す前に、安全性や有効性に関するデータを提出し、規制当局に認可を受ける必要があります。このプロセスにより、消費者に対して信頼性の高い選択肢を提供しています。 次に、一般用医薬品の特徴について述べます。一つ目は、自己治療が可能であることです。一般用医薬品は、軽い風邪や頭痛、消化不良などの症状を主に対象としており、患者自身がその症状を判断し、適切な医薬品を選ぶことができるように設計されています。また、これらの薬には通常、優れた安全性と副作用が少ないことが求められます。 二つ目の特徴として、容易なアクセスがあります。一般用医薬品は、薬局だけでなく、スーパーマーケットやコンビニエンスストアでも購入できるため、消費者は必要なときにすぐに手に入れることができます。さらに、これにより医療機関の負担を軽減し、より多くの患者が必要な治療を受けやすくなります。 三つ目は、使用に関する情報が明確であることです。一般用医薬品には、使用方法や用量、副作用、注意事項などがパッケージに詳しく記載されています。これにより、消費者は自分自身の症状に合った医薬品を正しく選び、安全に使用するための情報を得ることができます。 一般用医薬品の種類には、いくつかのカテゴリーがあります。まず、鎮痛剤や解熱剤、抗ヒスタミン薬、消化薬、湿疹やアレルギーに対する外用薬などがあります。これらは、すべて軽度から中程度の症状を対象とした薬です。例えば、鎮痛剤は頭痛や関節痛を和らげるために使用され、解熱剤は発熱時に体温を下げる役割を果たします。抗ヒスタミン薬はアレルギー症状を軽減し、消化薬は胃腸の不快感を緩和するために用いられます。 一般用医薬品は、その用途に応じて様々な形状やフォーミュレーションが存在します。錠剤、カプセル、液体、外用薬クリームなど、使用目的や患者のニーズに応じた形状が採用されています。これにより、患者は自分に適した投薬方法を選ぶことができ、服用しやすくなるという利点があります。 一般用医薬品の更なる重要な側面は、関連技術の進展です。製薬業界では、効果や安全性を向上させるための研究開発が日々行われており、科学技術の進歩に伴い、新しい成分や製剤技術の導入が進められています。また、製品のパッケージや表示の工夫により、患者にとって理解しやすい情報提供が行われています。たとえば、QRコードを用いて、製品情報や使用方法を簡単に確認できるようにする取り組みも見られます。 現在、一般用医薬品市場は急成長しており、多くの国で需要が増加しています。これは、自己治療の需要が高まっていることや、医療制度へのアクセスが限定されている地域においても、簡単に入手できる医薬品の必要性が高まっているためです。特に、パンデミックを経て、自己管理や予防に対する関心が高まったことも影響しています。 まさに今、一般用医薬品は生活の質を向上させるための重要な役割を担っており、将来的にはさらなる医薬品の開発や新しい使用法、さらにはデジタルヘルスと連携したサービスなどを通じて、より幅広い用途が期待されます。一方で、自身の健康管理において自分自身で選択することの重要性が強調されているため、利用者は情報をもとに慎重に判断することが求められています。 以上のように、一部の特徴や種類、関連情報について述べてきましたが、一般用医薬品は、多くの人々の健康と生活に寄与する重要な要素であることは間違いありません。安全性や効果については引き続き研究が必要ですが、消費者が賢明な選択をするための情報提供が行われることで、今後さらに役立つ医薬品の提供が期待されます。 |